Lakshmi A. Devi

Research.com Recognitions

• 2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Best Publications

• G-protein-coupled receptor heterodimerization modulates receptor function

  Bryen A. Jordan;Lakshmi A. Devi

  1525
  Citations

• Heterodimerization of mu and delta opioid receptors: A role in opiate synergy.

  I. Gomes;B. A. Jordan;A. Gupta;N. Trapaidze

  673
  Citations

• Dimerization of the delta opioid receptor: implication for a role in receptor internalization.

  Svetlana Cvejic;Lakshmi A. Devi

  652
  Citations

• G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives

  Sergi Ferré;Vicent Casadó;Lakshmi A. Devi;Marta Filizola

  607
  Citations

• A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia

  Ivone Gomes;Achla Gupta;Julija Filipovska;Hazel H. Szeto

  500
  Citations

• The emerging functions of endocannabinoid signaling during CNS development

  Tibor Harkany;Manuel Guzmán;Ismael Galve-Roperh;Paul Berghuis

  492
  Citations

• Building a new conceptual framework for receptor heteromers

  Sergi Ferré;Ruben Baler;Michel Bouvier;Marc G. Caron

  479
  Citations

• Oligomerization of opioid receptors with β2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation

  B. A. Jordan;N. Trapaidze;I. Gomes;R. Nivarthi;R. Nivarthi

  461
  Citations

• Bax cleavage is mediated by calpain during drug-induced apoptosis

  David E Wood;Anju Thomas;Anju Thomas;Lakshmi A Devi;Yemiliya Berman

  413
  Citations

• G-protein-coupled receptor dimerization: modulation of receptor function

  C.D. Rios;B.A. Jordan;I. Gomes;L.A. Devi

  410
  Citations

• μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis

  Carl Rios;Ivone Gomes;Lakshmi A Devi

  387
  Citations

• Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking.

  Lakshmi A Devi

  355
  Citations

• International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers

  Jean Philippe Pin;Richard Neubig;Michel Bouvier;Lakshmi Devi

  326
  Citations

• Hemopressin is an inverse agonist of CB1 cannabinoid receptors.

  Andrea S. Heimann;Ivone Gomes;Camila S. Dale;Rosana L. Pagano

  275
  Citations

• Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.

  Lloyd D. Fricker;Audra A. McKinzie;Jilin Sun;Eileen Curran

  273
  Citations

• Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.

  M. Ellgren;A. Artmann;O. Tkalych;A. Gupta

  265
  Citations

• G Protein–Coupled Receptor Heteromers

  Ivone Gomes;Mohammed Akli Ayoub;Wakako Fujita;Wakako Fujita;Werner C. Jaeger

  265
  Citations

• D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.

  Elizabeth A. Bolan;Bronwyn Kivell;Vanaja Jaligam;Murat Oz

  263
  Citations

• Receptor heterodimerization leads to a switch in signaling: β-arrestin2-mediated ERK activation by μ-δ opioid receptor heterodimers

  Raphael Rozenfeld;Lakshmi A. Devi

  261
  Citations

• Carboxypeptidase E activity is deficient in mice with the fat mutation. Effect on peptide processing.

  Lloyd D. Fricker;Yemiliya L. Berman;Edward H. Leiter;Lakshmi A. Devi

  245
  Citations